Menne J - Search Results

1

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults.

Barbour T, Scully M, Ariceta G, Cataland S, Garlo K, Heyne N, Luque Y, Menne J, Miyakawa Y, Yoon SS, Kavanagh D; 311 Study Group Members. Barbour T, et al. Among authors: menne j. Kidney Int Rep. 2021 Mar 24;6(6):1603-1613. doi: 10.1016/j.ekir.2021.03.884. eCollection 2021 Jun. Kidney Int Rep. 2021. PMID: 34169200 Free PMC article.

2

Uremia causes endothelial progenitor cell deficiency.

de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D. de Groot K, et al. Among authors: menne j. Kidney Int. 2004 Aug;66(2):641-6. doi: 10.1111/j.1523-1755.2004.00784.x. Kidney Int. 2004. PMID: 15253717 Free article.

3

[Kidney and hypertension].

Menne J, Fliser D, Haller H. Menne J, et al. Herz. 2006 Jun;31(4):317-21. doi: 10.1007/s00059-006-2820-z. Herz. 2006. PMID: 16810471 Review. German.

4

Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo.

Menne J, Meier M, Park JK, Boehne M, Kirsch T, Lindschau C, Ociepka R, Leitges M, Rinta-Valkama J, Holthofer H, Haller H. Menne J, et al. Kidney Int. 2006 Oct;70(8):1456-62. doi: 10.1038/sj.ki.5001830. Epub 2006 Sep 6. Kidney Int. 2006. PMID: 16955103 Free article.

5

Spotlight on renin: intrarenal renin-angiotensin system--important player of the local milieu.

Haller H, Park JK, Lindschau C, Meyer M, Menne J; Renin Academy. Haller H, et al. Among authors: menne j. J Renin Angiotensin Aldosterone Syst. 2006 Jun;7(2):122-5. doi: 10.3317/jraas.2006.009. J Renin Angiotensin Aldosterone Syst. 2006. PMID: 17083066 Free article. No abstract available.

6

Fixed-dose lercanidipine/enalapril for hypertension.

Menne J, Haller H. Menne J, et al. Drugs Today (Barc). 2008 Apr;44(4):261-70. doi: 10.1358/dot.2008.44.4.1164756. Drugs Today (Barc). 2008. PMID: 18536784 Review.

7

Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial.

Menne J, Farsang C, Deák L, Klebs S, Meier M, Handrock R, Sieder C, Haller H. Menne J, et al. J Hypertens. 2008 Sep;26(9):1860-7. doi: 10.1097/HJH.0b013e32830508aa. J Hypertens. 2008. PMID: 18698222 Clinical Trial.

8

Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.

Meier M, Menne J, Haller H. Meier M, et al. Among authors: menne j. Diabetologia. 2009 May;52(5):765-75. doi: 10.1007/s00125-009-1278-y. Epub 2009 Feb 24. Diabetologia. 2009. PMID: 19238353 Review.

9

Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.

Park JK, Mervaala EM, Muller DN, Menne J, Fiebeler A, Luft FC, Haller H. Park JK, et al. Among authors: menne j. J Hypertens. 2009 Mar;27(3):599-605. doi: 10.1097/HJH.0b013e32831ef369. J Hypertens. 2009. PMID: 19262227

10

How to achieve renal protection in the light of ONTARGET?

Chatzikyrkou C, Menne J, Haller H. Chatzikyrkou C, et al. Among authors: menne j. J Hypertens Suppl. 2009 Jun;27(2):S15-7. doi: 10.1097/01.hjh.0000354514.59827.04. J Hypertens Suppl. 2009. PMID: 19491616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters